These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 23696226)

  • 1. CEACAM1 on activated NK cells inhibits NKG2D-mediated cytolytic function and signaling.
    Hosomi S; Chen Z; Baker K; Chen L; Huang YH; Olszak T; Zeissig S; Wang JH; Mandelboim O; Beauchemin N; Lanier LL; Blumberg RS
    Eur J Immunol; 2013 Sep; 43(9):2473-83. PubMed ID: 23696226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CEACAM1 dampens antitumor immunity by down-regulating NKG2D ligand expression on tumor cells.
    Chen Z; Chen L; Baker K; Olszak T; Zeissig S; Huang YH; Kuo TT; Mandelboim O; Beauchemin N; Lanier LL; Blumberg RS
    J Exp Med; 2011 Dec; 208(13):2633-40. PubMed ID: 22143889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carcinoembryonic antigen (CEA) inhibits NK killing via interaction with CEA-related cell adhesion molecule 1.
    Stern N; Markel G; Arnon TI; Gruda R; Wong H; Gray-Owen SD; Mandelboim O
    J Immunol; 2005 Jun; 174(11):6692-701. PubMed ID: 15905509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EpCAM-high liver cancer stem cells resist natural killer cell-mediated cytotoxicity by upregulating CEACAM1.
    Park DJ; Sung PS; Kim JH; Lee GW; Jang JW; Jung ES; Bae SH; Choi JY; Yoon SK
    J Immunother Cancer; 2020 Mar; 8(1):. PubMed ID: 32221015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic signals for natural cytotoxicity are required to overcome inhibition by c-Cbl ubiquitin ligase.
    Kim HS; Das A; Gross CC; Bryceson YT; Long EO
    Immunity; 2010 Feb; 32(2):175-86. PubMed ID: 20189481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vav1 controls DAP10-mediated natural cytotoxicity by regulating actin and microtubule dynamics.
    Graham DB; Cella M; Giurisato E; Fujikawa K; Miletic AV; Kloeppel T; Brim K; Takai T; Shaw AS; Colonna M; Swat W
    J Immunol; 2006 Aug; 177(4):2349-55. PubMed ID: 16887996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complementary phosphorylation sites in the adaptor protein SLP-76 promote synergistic activation of natural killer cells.
    Kim HS; Long EO
    Sci Signal; 2012 Jul; 5(232):ra49. PubMed ID: 22786724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NKG2D-DAP10 signaling recruits EVL to the cytotoxic synapse to generate F-actin and promote NK cell cytotoxicity.
    Wilton KM; Overlee BL; Billadeau DD
    J Cell Sci; 2019 Jul; 133(5):. PubMed ID: 31235500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HBsAg stimulates NKG2D receptor expression on natural killer cells and inhibits hepatitis C virus replication.
    Wang XX; Pan XB; Han JC; Cong X; Jin Q; Kong XS; Wei L; Feng B
    Hepatobiliary Pancreat Dis Int; 2018 Jun; 17(3):233-240. PubMed ID: 29625837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vav1-phospholipase C-γ1 (Vav1-PLC-γ1) pathway initiated by T cell antigen receptor (TCRγδ) activation is required to overcome inhibition by ubiquitin ligase Cbl-b during γδT cell cytotoxicity.
    Yin S; Zhang J; Mao Y; Hu Y; Cui L; Kang N; He W
    J Biol Chem; 2013 Sep; 288(37):26448-62. PubMed ID: 23897818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contrasting Effects of the Cytotoxic Anticancer Drug Gemcitabine and the EGFR Tyrosine Kinase Inhibitor Gefitinib on NK Cell-Mediated Cytotoxicity via Regulation of NKG2D Ligand in Non-Small-Cell Lung Cancer Cells.
    Okita R; Wolf D; Yasuda K; Maeda A; Yukawa T; Saisho S; Shimizu K; Yamaguchi Y; Oka M; Nakayama E; Lundqvist A; Kiessling R; Seliger B; Nakata M
    PLoS One; 2015; 10(10):e0139809. PubMed ID: 26439264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fratricide of natural killer cells dressed with tumor-derived NKG2D ligand.
    Nakamura K; Nakayama M; Kawano M; Amagai R; Ishii T; Harigae H; Ogasawara K
    Proc Natl Acad Sci U S A; 2013 Jun; 110(23):9421-6. PubMed ID: 23690625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-18 synergism with interleukin-2 in cytotoxicity and NKG2D expression of human natural killer cells.
    Qi YY; Lu C; Ju Y; Wang ZE; Li YT; Shen YJ; Lu ZM
    Asian Pac J Cancer Prev; 2014; 15(18):7857-61. PubMed ID: 25292077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Silencing human NKG2D, DAP10, and DAP12 reduces cytotoxicity of activated CD8+ T cells and NK cells.
    Karimi M; Cao TM; Baker JA; Verneris MR; Soares L; Negrin RS
    J Immunol; 2005 Dec; 175(12):7819-28. PubMed ID: 16339517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered NKG2D function in NK cells induced by chronic exposure to NKG2D ligand-expressing tumor cells.
    Coudert JD; Zimmer J; Tomasello E; Cebecauer M; Colonna M; Vivier E; Held W
    Blood; 2005 Sep; 106(5):1711-7. PubMed ID: 15886320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CEACAM1-3S Drives Melanoma Cells into NK Cell-Mediated Cytolysis and Enhances Patient Survival.
    Ullrich N; Heinemann A; Nilewski E; Scheffrahn I; Klode J; Scherag A; Schadendorf D; Singer BB; Helfrich I
    Cancer Res; 2015 May; 75(9):1897-907. PubMed ID: 25744717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NKG2D Signaling Leads to NK Cell Mediated Lysis of Childhood AML.
    Schlegel P; Ditthard K; Lang P; Mezger M; Michaelis S; Handgretinger R; Pfeiffer M
    J Immunol Res; 2015; 2015():473175. PubMed ID: 26236752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A bispecific protein rG7S-MICA recruits natural killer cells and enhances NKG2D-mediated immunosurveillance against hepatocellular carcinoma.
    Wang T; Sun F; Xie W; Tang M; He H; Jia X; Tian X; Wang M; Zhang J
    Cancer Lett; 2016 Mar; 372(2):166-78. PubMed ID: 26791237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immunoediting of natural killer cells by human nasopharyngeal carcinoma cell line: altered expression of KIRs and NKG2D receptors leads to reduction of natural killer cell-mediated cytolysis].
    Guo KY; Mei JZ; Yao KT
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Mar; 27(3):247-9. PubMed ID: 17425963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Monoclonal Antibody NEO-201 Enhances Natural Killer Cell Cytotoxicity Against Tumor Cells Through Blockade of the Inhibitory CEACAM5/CEACAM1 Immune Checkpoint Pathway.
    Fantini M; David JM; Annunziata CM; Morelli MP; Arlen PM; Tsang KY
    Cancer Biother Radiopharm; 2020 Apr; 35(3):190-198. PubMed ID: 31928422
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.